MIAMI BEACH—Managing head and neck cancer involves high-stakes decisions that are full of nuance, with a need to weigh factors that range from a patient’s history to co-morbidities to tumor grade and location. Through the presentation of two clinical scenarios, a panel of experts dug into the details of case management of head and neck carcinoma during the Triological Society Combined Sections Meeting, held January 22–24 in Miami Beach, Fla.
Explore this issue:April 2016
Case 1: Left Parotid Tail Mass
A 38-year-old white female with a new-onset, 2-cm, left parotid tail mass has a history of Hodgkin’s lymphoma, for which she has undergone five courses of R-CHOP chemotherapy.
Francisco Civantos, MD, co-director of the division of head and neck surgery/otolaryngology at the University of Miami’s Sylvester Comprehensive Cancer Center in Florida, asked whether there was anything remarkable in her clinical exam. Panel moderator and case presenter Dennis Kraus, MD, director of the Center for Head and Neck Oncology at the New York Head and Neck Institute, said the patient reported that she generally felt pretty well.| | | Next → | Single Page